tiprankstipranks
Rocket Pharmaceuticals (RCKT)
NASDAQ:RCKT
US Market
RCKT
Rocket Pharmaceuticals
RESEARCH TOOLSreports

Rocket Pharmaceuticals (RCKT) Stock News & Sentiment

1,715 Followers
Balancing Early Gene Therapy Validation Against Limited Near-Term Revenue and Pipeline Risk: Rationale for Maintaining a Hold on Rocket
Premium
Ratings
Balancing Early Gene Therapy Validation Against Limited Near-Term Revenue and Pipeline Risk: Rationale for Maintaining a Hold on Rocket
14d ago
RCKT
Rocket Pharmaceuticals: FDA Validation, Non-Dilutive Funding Catalyst, and Pipeline De-Risking Support Buy Rating
Premium
Ratings
Rocket Pharmaceuticals: FDA Validation, Non-Dilutive Funding Catalyst, and Pipeline De-Risking Support Buy Rating
17d ago
RCKT
Rocket Pharmaceuticals: Kresladi Approval, Non‑Dilutive Capital, and Danon Pipeline Progress Underscore Buy Rating Despite Share Weakness
Premium
Ratings
Rocket Pharmaceuticals: Kresladi Approval, Non‑Dilutive Capital, and Danon Pipeline Progress Underscore Buy Rating Despite Share Weakness
17d ago
RCKT
Rocket Pharmaceuticals: First Approval and Extended Cash Runway Offset by Long Path to Meaningful Kresladi Revenues, Warranting a Hold Rating
Premium
Ratings
Rocket Pharmaceuticals: First Approval and Extended Cash Runway Offset by Long Path to Meaningful Kresladi Revenues, Warranting a Hold Rating
17d ago
RCKT
Rocket Pharmaceuticals wins FDA nod for KRESLADI gene therapy
Premium
Company Announcements
Rocket Pharmaceuticals wins FDA nod for KRESLADI gene therapy
17d ago
8K
RCKT
Rocket Pharmaceuticals: FDA Approval of Kresladi Marks Strategic Inflection Point Supporting Buy Rating
Premium
Ratings
Rocket Pharmaceuticals: FDA Approval of Kresladi Marks Strategic Inflection Point Supporting Buy Rating
17d ago
RCKT
Rocket Pharma Advances BAG3 Heart Disease Study, Bolstering Long-Term Gene Therapy Story
Premium
Company Announcements
Rocket Pharma Advances BAG3 Heart Disease Study, Bolstering Long-Term Gene Therapy Story
24d ago
RCKT
More RCKT News >

RCKT News on the Web

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT) and Moderna (MRNA)
TipRanks News
Neutral
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease
Zacks
Bearish
Rocket Pharmaceuticals price target raised to $9 from $8 at BofA
TipRanks News
Bullish
Balancing Early Gene Therapy Validation Against Limited Near-Term Revenue and Pipeline Risk: Rationale for Maintaining a Hold on Rocket
TipRanks News
Neutral
Rocket Pharmaceuticals price target raised to $11 from $9 at Leerink
TipRanks News
Bullish
PRV reception could net Rocket $100M-$200M, says LifeSci Capital
TipRanks News
Bullish
Rocket Pharmaceuticals stock weakness unwarranted, says Wedbush
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RCKT’s Media Buzz Sentiment?
Currently, no data Available
What is RCKT’s weekly average amount of articles?
Currently, no data Available
What is RCKT’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
TXTMProText Mobility
STAAStaar Surgical
IVVDInvivyd
ALLOAllogene Therapeutics
Showing the stocks with the most bullish news sentiment over the past week